Genesis

company on 8 shows · 8 statements across 6 episodes · said 3 times in 1 episodes since 2024

All-In 3 Latent Space My First Million Capital Allocators Top Founders Big Technology TBPN 20VC

Mentions by year, every show

tap a year for its mentions
0021312024episodesmentions
0112024episodes it came up in
001.50.5312024episodesmentions per episode

All-In 3

2024 3 mentions in 1 episode

every mention on every show, scene by scene, with the transcript →

8 statements about Genesis, every show

BIG TECHNOLOGY Assertion Not checkable as stated
Bates: Genesys sees no seat contraction from AI
“We don't even see any contraction in seats. We see AI as a tailwind, like every one of the sort of, the narratives you hear aren't coming to pass.”
Tony Bates Sep 11, 2026 ▶ 31:00 Is The Future Customer Experience AI Talking To AI? — With Tony Bates
LATENT SPACE Assertion Not checkable as stated
Edunov: Physics-guided inference-time scaling significantly boosts molecular model performance
“We are doing very similar thing with our models where a model is forced to think, except it's not thinking in language tokens. It's thinking in terms of crystal structures, not fully materialized crystal structures, but some sort of a crystal structure represe…”
Sergei Yudinov Jun 30, 2026 ▶ 17:47 🔬 "The Most Innovative Diffusion Research Is Happening in Drug Discovery, Not Image Generation"
Edunov: Predicting ADMET properties is as critical as protein structure prediction
“Predicting all of those properties is also just as important as, or maybe even more important than predicting the crystal structure itself.”
Sergei Yudinov Jun 30, 2026 ▶ 37:45 🔬 "The Most Innovative Diffusion Research Is Happening in Drug Discovery, Not Image Generation"
LATENT SPACE Disclosure
Feinberg: Genesis is developing autonomous drug discovery agent platform 'Sapphire'
“We're working on an agentic platform for 24 seven drug discovery. If you can imagine just fleets of hundreds of med chemists and CAD scientists Working nights and weekends all the time for your drug targets. The code name for that gem is Sapphire.”
Evan Feinberg Jun 30, 2026 ▶ 48:21 🔬 "The Most Innovative Diffusion Research Is Happening in Drug Discovery, Not Image Generation"
20VC Assertion Not checkable as stated
Shurtz: Genesys requires close to $100M contract value for dedicated account coverage
“If I thought about Genesis, you would need to be, you'd probably need to be close to a nine digit customer.”
Larry Shurtz May 10, 2024 ▶ 47:25 Larry Shurtz: How to Hire, Train & Retain the Best Vertical Teams | E1151 · 20VC with Harry Stebbings
Wittmeyer: I Have Capital Trapped on Genesis
“We have, I have money on Genesis that I don't know what's going to happen to it, but that one was pretty stunning too.”
Mike Wittmeyer Dec 17, 2022 ▶ 1:22:24 BREAKING: Shaan Sells the Milk Road - A Conversation With the Buyers
Sonnenshein: Grayscale relies on sister firm Genesis for all asset sourcing
“So our authorized participant and does all of our sourcing and trading for us is our sister firm called Genesis. They're a broker dealer based here in New York.”
Michael Sonnenshein Mar 11, 2021 ▶ 33:33 Crypto for Institutions 2 – Michael Sonnenshein – A Path to Entry (Capital Allocators, EP.181)
TOP FOUNDERS Assertion Partly supported
Shamia: Call center market is $22B dominated by legacy incumbents
“The call center space is a twenty-two billion dollar market. It's still dominated by old players like Avaya and Cisco and Genesis that sell the same system for 2030 years.”
Gadi Shamia Jun 1, 2017 ▶ 4:18 677: Talkdesk Passes 50,000 Seats, $25M Raised To Be Your More Efficient Call Center with COO Gadi Shamia

← every entity, every show

Made with StarZero

Turn any episode into a week of clips.

This entire site, thousands of episodes across every show transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.